Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals including Strategic National Stockpile appropriations and reauthorization of the Pandemic and All-Hazards Preparedness Act, S.2333, Pandemic and All-Hazards Preparedness and Response Act, H.R.4421, Preparing for All Hazards and Pathogens Reauthorization Act; Appropriations - S.2624/HR 5894, the Fiscal Year 2024
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024; Implementation of H.R.2617, Consolidated Appropriations Act, 2023
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2023: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS)
Bills mentioned
S.2333: Pandemic and All-Hazards Preparedness and Response Act
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Registration
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate